Annual Short Term Debt
$173.00 K
+$86.00 K+98.85%
31 December 2023
Summary:
Oncternal Therapeutics annual short term debt is currently $173.00 thousand, with the most recent change of +$86.00 thousand (+98.85%) on 31 December 2023. During the last 3 years, it has risen by +$133.00 thousand (+332.50%). ONCT annual short term debt is now at all-time high.ONCT Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$191.00 K
+$6000.00+3.24%
30 September 2024
Summary:
Oncternal Therapeutics quarterly short term debt is currently $191.00 thousand, with the most recent change of +$6000.00 (+3.24%) on 30 September 2024. Over the past year, it has increased by +$40.00 thousand (+26.49%). ONCT quarterly short term debt is now at all-time high.ONCT Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONCT Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +98.8% | +26.5% |
| 3 y3 years | +332.5% | +60.5% |
| 5 y5 years | - | +99.0% |
ONCT Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +332.5% | at high | +516.1% |
| 5 y | 5 years | at high | +332.5% | at high | +516.1% |
| alltime | all time | at high | +332.5% | at high | +516.1% |
Oncternal Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $191.00 K(+3.2%) |
| June 2024 | - | $185.00 K(+3.4%) |
| Mar 2024 | - | $179.00 K(+3.5%) |
| Dec 2023 | $173.00 K(+98.9%) | $173.00 K(+14.6%) |
| Sept 2023 | - | $151.00 K(+4.1%) |
| June 2023 | - | $145.00 K(+190.0%) |
| Mar 2023 | - | $50.00 K(-42.5%) |
| Dec 2022 | $87.00 K(+16.0%) | $87.00 K(-28.7%) |
| Sept 2022 | - | $122.00 K(-15.3%) |
| June 2022 | - | $144.00 K(+364.5%) |
| Mar 2022 | - | $31.00 K(-58.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $75.00 K(+87.5%) | $75.00 K(-37.0%) |
| Sept 2021 | - | $119.00 K(-26.5%) |
| June 2021 | - | $162.00 K(-6.4%) |
| Mar 2021 | - | $173.00 K(+332.5%) |
| Dec 2020 | $40.00 K(-59.6%) | $40.00 K(-49.4%) |
| Sept 2020 | - | $79.00 K(-32.5%) |
| June 2020 | - | $117.00 K(+15.8%) |
| Mar 2020 | - | $101.00 K(+2.0%) |
| Dec 2019 | $99.00 K(+20.7%) | $99.00 K(+3.1%) |
| Sept 2019 | - | $96.00 K(-30.9%) |
| June 2019 | - | $139.00 K(+69.5%) |
| Dec 2011 | $82.00 K | $82.00 K |
FAQ
- What is Oncternal Therapeutics annual short term debt?
- What is the all time high annual short term debt for Oncternal Therapeutics?
- What is Oncternal Therapeutics annual short term debt year-on-year change?
- What is Oncternal Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Oncternal Therapeutics?
- What is Oncternal Therapeutics quarterly short term debt year-on-year change?
What is Oncternal Therapeutics annual short term debt?
The current annual short term debt of ONCT is $173.00 K
What is the all time high annual short term debt for Oncternal Therapeutics?
Oncternal Therapeutics all-time high annual short term debt is $173.00 K
What is Oncternal Therapeutics annual short term debt year-on-year change?
Over the past year, ONCT annual short term debt has changed by +$86.00 K (+98.85%)
What is Oncternal Therapeutics quarterly short term debt?
The current quarterly short term debt of ONCT is $191.00 K
What is the all time high quarterly short term debt for Oncternal Therapeutics?
Oncternal Therapeutics all-time high quarterly short term debt is $191.00 K
What is Oncternal Therapeutics quarterly short term debt year-on-year change?
Over the past year, ONCT quarterly short term debt has changed by +$40.00 K (+26.49%)